In our MLL-AF9 leukemia model studies [50], SALL4 appears to recruit both DOT1L and LSD1 to specific downstream target genes and modulate their H3K79me2/3 and H3K4me3 levels, thereby maintaining proper gene expression and leukemic survival (see Fig. 1). This evidence concerns the gene KDM1A and leukemia.